Pharmaceutically acceptable salts of pyrrolo-nitrogenous heterocyclic derivatives, preparation method and medical use thereof

Details for Australian Patent Application No. 2011213440 (hide)

Owner Shanghai Hengrui Pharmaceutical Co., Ltd. Jiangsu Hengrui Medicine Co., Ltd.

Inventors Tang, Peng Cho

Agent Fisher Adams Kelly

Pub. Number AU-A-2011213440

PCT Pub. Number WO2011/095068

Priority 201010109068.5 04.02.10 CN

Filing date 7 January 2011

Wipo publication date 11 August 2011

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 35/00 Antineoplastic agents

Event Publications

9 August 2012 PCT application entered the National Phase

  PCT publication WO2011/095068 Priority application(s): WO2011/095068

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011213445-Method and apparatus for filtering malicious calling completion indicating and network device of calling side thereof

2011213438-Magnetic levitation supporting structure for vertical shaft disc-type motor